ECUBLENS, SWITZERLAND – Oct. 28, 2013 – Symetis Inc., a privately-owned Swiss company focused on transcatheter aortic valve implantation (TAVI) systems announced today that it has achieved a symbolic milestone: the implantation of the 1000th ACURATE TA™ transaortic valve. The first ACURATE TA™ valve was implanted in November 2009 [...]
Former Worldwide VP for Regulatory Affairs at Johnson & Johnson Brings Vast Experience in Medical Device Submissions, Approvals and GMP Compliance. MONTREUX, Switzerland, April 13, 2010 – CeQur SA, a company focused on the development and commercialization of insulin delivery systems to improve the management of type 2 diabetes, [...]
CAMBRIDGE, Mass. (EON: Enhanced Online News) BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, announced today the pricing of its initial public offering of 4,700,000 shares of its common stock at a public offering price of $15.00 per share, before underwriting discounts [...]